Skip to content
Lucky House

Zimbabwe Turns Down ‘One-Sided’ American Health Aid Deal Due to Data Fears

Health funding illustration
The offered US financial assistance was intended for programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has turned down a significant American health deal worth 367 million US dollars (£272m) spanning five years due to the United States' request for confidential biological samples.

The decision came to light following a government memo dated December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the agreement was "unbalanced".

An official spokesman has since explained that the United States was requesting genetic material for scientific study and commercial purposes while was unwilling to share the resulting advantages from future medical innovations.

"We are forced to start the difficult and regrettable process of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy noted the United States had donated more than $1.9bn as health assistance to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has appealed for continued negotiations to find a deal suitable to all parties so the nation's critical HIV treatment initiative can be sustained.

Wider Context

This rejection comes after a similar case in Kenya, where a high court suspended a related health funding agreement after concerns were raised about the safety of citizens' health data.

After returning to office recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).

USAID had administered aid for the American government, but Trump argued its spending was "wasteful" and his government was pursuing direct bilateral deals to enhance transparency and responsibility.

Based on statements, Sixteen nations in Africa have so far agreed to these new health pacts, constituting over $18.3bn in committed funds.

Details of the Declined Agreement

The funds for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this collaboration might have yielded immense benefits for Zimbabwean communities, particularly the 1.2 million presently receiving antiretroviral therapy via American-funded programmes," Tremont commented.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".

"The proposal required Zimbabwe to share its genetic material and health information for a long time, without any corresponding assurance of access to any scientific breakthroughs – like new medicines or tests – that might result from that provided information," his statement read.

"Put simply, our nation would provide the raw materials for medical research with no assurance that the end products would be available to our people if a new disease outbreak emerge."

Sovereignty and International Frameworks

He also noted that the US's withdrawal from the global health body and its push of one-on-one health agreements were undermining systems previously established through the global health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with potential pandemics.

"This mechanism is intended to guarantee that when a country provides its data, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised solely by those with the capability to create them."

These objections regarding the US deal "must not be interpreted as opposition to America," he added.

"We welcome continued discussions with our US partners on how subsequent co-operation might be arranged in a way that respects the sovereignty and dignity of each country."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but suggested that talks must proceed since much of the country's Aids initiatives relied on external financing.

"In cases where technical issues arise, including those relating to data governance or agreement terms, these can often be addressed via technical clarification and negotiated safeguards," it added.

The situation highlights the ongoing debate between receiving crucial foreign assistance and protecting a country's data in an ever more data-driven world.

The writer

Mary Drake

Elara is a passionate interior designer and lifestyle blogger, sharing her expertise in home decor and sustainable living.

Lucky House

Type to search articles.